Acino Russia was recently recognized as a valuable partner to the field of colorectal surgery and treatment, receiving an award from the prestigious Russian School of colorectal surgery at their recent global conference. In its 12th year, the event brings together leading colorectal specialists from around the world, including the United States, Asia and Europe.
The event, over three days, is an opportunity for medical specialists, practitioners and researchers to share insights and knowledge in the colorectal field.
In their first year of participation, Acino Russia supported more than 1000 specialists to gain awareness and understanding of new products and treatment option and methods for colorectal diseases, particularly personalized hemorrhoids treatment.
In the closing ceremony, Acino Russia was recognized by the society as a valuable partner and contributor to the field of colorectal treatment and the event. The award was handed over by the Director of the Russian School of colorectal surgery, Dr.Petr Tsarkov.
Ekaterina Butolina, Product Manager, accepted the award on stage:
‘We were really surprised to be given this award, but of course we were delighted!
‘Our motivation as a company and team is to promote high-quality healthcare, and to do this we need to support the medical community at fantastic events such as this. It was really good to discuss science, innovation and how to improve treatments for patients.
‘We are looking forward to an ongoing partnership and to the next events!’
Our entity in Russia is a fast-growing pharmaceutical company with an exclusive portfolio of original products for diverse therapeutic areas focusing on female healthcare and cardiology. The well-established team with a strong expertise both in retail and hospital segments works to promote products throughout the country. In total, over 70 employees located in more than 25 cities of Russia deliver healthcare solutions to patients with high quality and maximum safety as well as educational activities for the healthcare community.
With our focus on cardiology and women health products we are holding leading positions in the women’s health segment and are ranked Top 5 in gynecology anti-infectives and Top 3 in simultaneous therapy of patients with acute coronary syndrome.
In the current situation of economic volatility, healthcare funding constraints and increased market competition our commercial and marketing teams expand their efforts to increase the knowledge about our products among healthcare professionals to make our high quality products available to patients.
With the support from key opinion leaders a series of over 40 targeted regional events for healthcare professionals have been held in different regions of Russia during 2016.
“These events provide plenty of opportunity to discuss clinical cases and to share their experiences which is of high value for both young and experienced healthcare professionals.”
Olga Gostishcheva, Medical Director
50 cardiologists attended our healthcare forum for cardiologists ‘Preventing post-surgery complications after percutaneous coronary intervention at acute coronary syndrome’ that was held in May 2016 in Moscow. Leading professors presented during the forum and actively involved participants into discussions, and demonstrated medical cases from their medical practice.
